Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Noom Inc

Noom Unveils New Diabetes Lifestyle Program and Predictive Glucose Forecasting to Tackle America’s Diabetes Crisis
From Noom Inc
Via GlobeNewswire
Noom Launches AI Face Scan and AI Future Me to Bring Preventive Health Insights to Everyone
From Noom Inc
Via GlobeNewswire
Noom Introduces “Mindful Art Break” — A Weekly Practice Designed to Spark Awe, Relieve Stress, and Boost Psychological Wellbeing
From Noom Inc
Via GlobeNewswire
Noom Welcomes Rebel Wilson as Chief Wellness Ambassador to Champion Microhabits and Microdose GLP-1s
From Noom Inc
Via GlobeNewswire
Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program
From Noom Inc
Via GlobeNewswire
Noom Invited to White House to Pledge to the CMS Digital Health Ecosystem Shared Framework Empowering People, Integrating AI, and Accelerating Healthcare Access
From Noom Inc
Via GlobeNewswire
Noom Expands Board of Directors with Appointment of Global Health Leader Dr. David Luu
From Noom Inc
Via GlobeNewswire
Noom Launches Free Menopause Education Hub in Partnership with Menopause Advocate Tamsen Fadal
From Noom Inc
Via GlobeNewswire
Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity
From Noom Inc
Via GlobeNewswire
Noom To Streamline Access to Zepbound® Vials with Noom GLP-1 Companion Through Integration with LillyDirect® Pharmacy Provider
From Noom Inc
Via GlobeNewswire
Noom Expands into Hormone Replacement Therapy to Support Women’s Health and Well-being
From Noom Inc
Via GlobeNewswire
Noom Introduces Free AI-Powered Personalized Health Report to Promote Living Better Longer
From Noom Inc
Via GlobeNewswire
Noom’s GLP-1 Companion Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model
From Noom Inc
Via GlobeNewswire
Noom Offers Oral Medications For Weight Loss Starting at $29
From Noom Inc
Via GlobeNewswire
Noom Unveils Two New Enterprise Products to Help Employers Offer, Manage, and Effectively Control GLP-1 Expenses
From Noom Inc
Via GlobeNewswire
Noom Introduces Innovative In-App Body Scan Technology to Monitor Muscle-Mass Retention During GLP-1 Treatment
From Noom Inc
Via GlobeNewswire
Noom Strengthens Healthcare Team by Adding Women’s Health Experts
From Noom Inc
Via GlobeNewswire
Yalda Olcott, PharmD, Joins Noom as Head of Healthcare and Pharmacy Operations
From Noom Inc
Via GlobeNewswire
Noom Calls for Affordable Choices and Fair Pricing of Weight-Loss Medications Ahead of Tuesday’s Senate Testimony
From Noom Inc
Via GlobeNewswire
Noom Appoints Rachel Mahoney as Chief Brand Officer
From Noom Inc
Via GlobeNewswire
Noom Introduces Industry-First $149 Compounded GLP-1 with a Taper-Off Guarantee, Offering a Sustainable Approach to Long-Term Weight Loss
From Noom Inc
Via GlobeNewswire
Noom Introduces AI-Enabled Products to Enhance On-Demand Health Care and Interactive Coaching
From Noom Inc
Via GlobeNewswire
Noom Announces Strategic Expansion of Executive Team with Key Leadership Appointments
From Noom Inc
Via GlobeNewswire
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
From Noom Inc
Via GlobeNewswire
Noom Adds Muscle Defense™ to Its GLP-1 Companion Program to Help Prevent Muscle-Mass Loss While Taking GLP-1s
From Noom Inc
Via GlobeNewswire
Noom Establishes Its First-Ever Social Impact Program with the Launch of Noom Impact, Providing Free Health Solutions to People in Need
From Noom Inc
Via GlobeNewswire
Noom Strengthens Commercial Leadership Team with Trio of Executive Healthcare Appointments
From Noom Inc
Via GlobeNewswire
Noom Earns Highest CDC Recognition for Diabetes Prevention Program
From Noom Inc
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.